Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis

ObjectivesTo compare the cross-sectional robustness of commonly used volumetric software and effects of lesion filling in multiple sclerosis (MS).MethodsNine MS patients (six females; age 38±13 years, disease duration 7.3±5.2 years) were scanned twice with repositioning on three MRI scanners (Siemens Aera 1.5T, Avanto 1.5T, Trio 3.0T) the same day. Volumetric T1-weighted images were processed with FreeSurfer, FSL-SIENAX, SPM and SPM-CAT before and after 3D FLAIR lesion filling with LST. The whole-brain, grey matter (GM) and white matter (WM) volumes were calculated with and without normalisation to the intracranial volume or FSL-SIENAX scaling factor. Robustness was assessed using the coefficient of variation (CoV).ResultsVariability in volumetrics was lower within than between scanners (CoV 0.17–0.96% vs. 0.65–5.0%, p<0.001). All software provided similarly robust segmentations of the brain volume on the same scanner (CoV 0.17–0.28%, p=0.076). Normalisation improved inter-scanner reproducibility in FreeSurfer and SPM-based methods, but the FSL-SIENAX scaling factor did not improve robustness. Generally, SPM-based methods produced the most consistent volumetrics, while FreeSurfer was more robust for WM volumes on different scanners. FreeSurfer had more robust normalised brain and GM volumes on different scanners than FSL-SIENAX (p=0.004). MS lesion filling changed the output of FSL-SIENAX, SPM and SPM-CAT but not FreeSurfer.ConclusionsConsistent use of the same scanner is essential and normalisation to the intracranial volume is recommended for multiple scanners. Based on robustness, SPM-based methods are particularly suitable for cross-sectional volumetry. FreeSurfer poses a suitable alternative with WM segmentations less sensitive to MS lesions.Key Points• The same scanner should be used for brain volumetry. If different scanners are used, the intracranial volume normalisation improves the FreeSurfer and SPM robustness (but not the FSL scaling factor).• FreeSurfer, FSL and SPM all provide robust measures of the whole brain volume on the same MRI scanner. SPM-based methods overall provide the most robust segmentations (except white matter segmentations on different scanners where FreeSurfer is more robust).• MS lesion filling with Lesion Segmentation Toolbox changes the output of FSL-SIENAX and SPM. FreeSurfer output is not affected by MS lesion filling since it already takes white matter hypointensities into account and is therefore particularly suitable for MS brain volumetry.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  F. Fazekas,et al.  Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis , 2012, Journal of Neurology.

[3]  Eric Westman,et al.  Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy , 2014, Journal of Neuroimmunology.

[4]  C Confavreux,et al.  Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques , 2012, American Journal of Neuroradiology.

[5]  Bruce Fischl,et al.  FreeSurfer , 2012, NeuroImage.

[6]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[7]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[8]  Bruce Fischl,et al.  Within-subject template estimation for unbiased longitudinal image analysis , 2012, NeuroImage.

[9]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[10]  Arvid Lundervold,et al.  Evaluation of automated brain MR image segmentation and volumetry methods , 2009, Human brain mapping.

[11]  O. Ciccarelli,et al.  Nonconventional MRI and microstructural cerebral changes in multiple sclerosis , 2015, Nature Reviews Neurology.

[12]  Ninon Burgos,et al.  New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .

[13]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[14]  Jeffrey A. Cohen,et al.  Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.

[15]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[16]  O. Ciccarelli,et al.  MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES , 2016, The Lancet Neurology.

[17]  Kuncheng Li,et al.  Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS , 2017, European Radiology.

[18]  Anders M. Dale,et al.  MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths , 2009, NeuroImage.

[19]  P. Lundberg,et al.  Novel whole brain segmentation and volume estimation using quantitative MRI , 2012, European Radiology.

[20]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[21]  Bernhard Hemmer,et al.  An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis , 2012, NeuroImage.

[22]  David H. Miller,et al.  Imaging outcomes for neuroprotection and repair in multiple sclerosis trials , 2009, Nature Reviews Neurology.

[23]  Anders M. Dale,et al.  Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.

[24]  P Aspelin,et al.  Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study , 2016, American Journal of Neuroradiology.

[25]  F. Barkhof,et al.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients , 2015, Nature Reviews Neurology.

[26]  K Kazemi,et al.  Quantitative Comparison of SPM, FSL, and Brainsuite for Brain MR Image Segmentation , 2014, Journal of biomedical physics & engineering.

[27]  Amir Alansary,et al.  MRBrainS Challenge: Online Evaluation Framework for Brain Image Segmentation in 3T MRI Scans , 2015, Comput. Intell. Neurosci..

[28]  L. Lönn,et al.  Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society , 2016, Acta neurologica Scandinavica.

[29]  Mark W. Woolrich,et al.  FSL , 2012, NeuroImage.

[30]  Mehul P. Sampat,et al.  Disease modeling in multiple sclerosis: Assessment and quantification of sources of variability in brain parenchymal fraction measurements , 2010, NeuroImage.

[31]  Mark Jenkinson,et al.  Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis , 2012, NeuroImage.

[32]  M. Viergever,et al.  Robustness of Automated Methods for Brain Volume Measurements across Different MRI Field Strengths , 2016, PloS one.

[33]  Anisha Keshavan,et al.  Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis , 2016, NeuroImage.

[34]  M. Battaglini,et al.  Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes , 2010, Neurology.

[35]  Christian Gaser,et al.  CAT-A Computational Anatomy Toolbox for the Analysis of Structural MRI Data , 2016 .

[36]  Xavier Lladó,et al.  Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling , 2015, NeuroImage: Clinical.

[37]  M. Battaglini,et al.  Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[38]  David H. Miller,et al.  Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes , 2010, Journal of magnetic resonance imaging : JMRI.